Stay updated on Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial
Sign up to get notified when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.

Latest updates to the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page's revision tag updates to v3.6.6, replacing the previous v3.6.5 to reflect a newer site build.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded the line '2016 ( U.S. NIH Grant/Contract )' to the study's identifiers, indicating an NIH funding reference in the Other Study ID Numbers section.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new page revision label Revision: v3.6.5 appears, replacing the prior label Revision: v3.6.4. This indicates a new build of the page was published, typically for maintenance or minor fixes.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision tag on the page updated from v3.6.3 to v3.6.4. This is a backend/system version bump and does not change the study details, eligibility criteria, or any information presented to users.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a new release iteration. This update affects the page's build/versioning rather than the displayed study details.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page shows an updated revision label from v3.6.0 to v3.6.2, reflecting a newer release of the page rather than changes to study data.SummaryDifference0.0%

Stay in the know with updates to Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel/Gemcitabine±Olaratumab in Metastatic Pancreatic Ca Clinical Trial page.